Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 include 660,000 shares of common stock, par value $0.01 per share ("Common Stock") of the Issuer that may be acquired by certain Reporting Persons within 60 days pursuant to an option agreement with a third-party to acquire shares of Common Stock (the "Option Agreement"). (2) The figure in Item 11 is based upon 28,873,415 shares of Common Stock outstanding as of August 7, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed on August 7, 2025, by the Issuer with the U.S. Securities and Exchange Commission (the "SEC").


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 include 660,000 shares of Common Stock of the Issuer that may be acquired by certain Reporting Persons within 60 days pursuant to the Option Agreement. (2) The figure in Item 11 is based upon 28,873,415 shares of Common Stock outstanding as of August 7, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed on August 7, 2025, by the Issuer with the SEC.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 include 306,504 shares of Common Stock of the Issuer, which is Fund 1's current allocable portion of the 660,000 shares of Common Stock of the Issuer that may be acquired within 60 days pursuant to the Option Agreement, which allocation is subject to change as determined by the Investment Manager in accordance with its allocation policies and procedures. (2) The figure in Item 11 is based upon 28,873,415 shares of Common Stock outstanding as of August 7, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed on August 7, 2025, by the Issuer with the SEC.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 include 353,496 shares of Common Stock of the Issuer, which is Fund 2's current allocable portion of the 660,000 shares of Common Stock of the Issuer that may be acquired within 60 days pursuant to the Option Agreement, which allocation is subject to change as determined by the Investment Manager in accordance with its allocation policies and procedures. (2) The figure in Item 11 is based upon 28,873,415 shares of Common Stock outstanding as of August 7, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed on August 7, 2025, by the Issuer with the SEC.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) The figures in Items 6, 8, and 9 include 660,000 shares of Common Stock of the Issuer that may be acquired by certain Reporting Persons within 60 days pursuant to the Option Agreement. (2) The figure in Item 11 is based upon 28,873,415 shares of Common Stock outstanding as of August 7, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed on August 7, 2025, by the Issuer with the SEC.


SCHEDULE 13G



 
Greenhaven Road Investment Management, L.P.
 
Signature:/s/ Scott Miller
Name/Title:Scott Miller, Authorized Signatory
Date:11/06/2025
 
MVM Funds LLC
 
Signature:/s/ Scott Miller
Name/Title:Scott Miller, Authorized Signatory
Date:11/06/2025
 
Greenhaven Road Capital Fund 1, L.P.
 
Signature:/s/ Scott Miller
Name/Title:Scott Miller, Authorized Signatory
Date:11/06/2025
 
Greenhaven Road Capital Fund 2, L.P.
 
Signature:/s/ Scott Miller
Name/Title:Scott Miller, Authorized Signatory
Date:11/06/2025
 
Miller Scott Stewart
 
Signature:/s/ Scott Miller
Name/Title:Scott Miller, Authorized Signatory
Date:11/06/2025
Exhibit Information

99.1 Joint Filing Agreement (filed herewith)